Results 111 to 120 of about 2,637,535 (301)

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Secularisation and Minority Rights—How Does Secularisation Affect the Rights of Religious and Belief Minorities?

open access: yesReligions
This article discusses the link between secularisation and the rights of religious and belief minorities. Using data from the Atlas of Religious or Belief Minority Rights, it measures the extent to which RBM rights are respected, promoted and restricted.
Silvio Ferrari   +5 more
doaj   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit   +11 more
wiley   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Minority and Indigenous Trends 2021: focus on COVID-19 [PDF]

open access: yes, 2021
Minority Rights Group International
core  

Judicial Adjudication of Language Rights in Central, Eastern, and South-Eastern Europe. Principles and Criteria. EDAP 2/2011 [PDF]

open access: yes, 2011
Central, Eastern, and South-Eastern Europe are among the regions where minority, including linguistic rights, are more developed, at least on paper. Not always, however, have these rights been fully and effectively implemented so far.
Palermo, Francesco., PALERMO, Francesco
core   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

A quest for equality : minorities in Turkey

open access: yes, 2007
Minority Rights Group InternationalParallel als Buch-Ausg ...
Minority Rights Group International
core  

MINORITY SHAREHOLDERS: GENERAL ISSUES ON THE DEFINITION OF THE CONCEPT AND MECHANISMS OF LEGAL PROTECTION

open access: yesPravo, 2017
THE protection of the rights of minority shareholders is an important issue of corporate governance and company law regulations, which has a transnational character.
Marija Tasić
doaj  

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy